Tilray’s complete product offering now the broadest medical cannabis offering from a Licensed Producer in the market
NANAIMO, B.C. –Tilray, Inc. (NASDAQ: TLRY), a global pioneer in cannabis research, cultivation, production, and distribution, today announced the launch of four new products in Australia, expanding the company’s product offering to include both medical cannabis oral solution and whole flower and marking it as the broadest medical cannabis offering from an Licensed Producer in Australia.
Tilray is one of the leading providers of medical cannabis in Australia and New Zealand for commercial, compassionate access and research purposes and was the first Licensed Producer to legally export medical cannabis from North America to Australia and New Zealand from its Good Manufacturing Practices (GMP)-certified facility in Canada.
“We’re proud to broaden our offering to include both whole flower and oral solutions. This new product mix provides more Australian patients with access to a selection of consumption methods